Neuphoria Therapeutics Inc. (NEUP) Operating margin 2025–2026
Neuphoria Therapeutics Inc. (NEUP) operating margin by fiscal year — reported operating income divided by reported revenue.
-1401.1%FY2026 · since FY2025: -7.2% → -1401.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -1401.1% | -1393.9 pp |
| FY2025 | -7.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice